Skip to main content
. 2012 Oct;194(19):5361–5367. doi: 10.1128/JB.01142-12

Table 2.

B. subtilis mutL missense mutation conserved in human MLH1a

B. subtilis mutL missense mutation Human MLH1 missense mutation No. of reported occurrences in humansb Potential functionc
A17V A21V 6 ATP binding
G18A G22A 11 ATP binding
P24L P28L 32 ATP hydrolysis
E30A E34A 4 ATP hydrolysis
N34H N38H 8 ATP hydrolysis
S40A S44A 5 ATP hydrolysis
N60S N64S 20 Unclear
G63R G67R 74 ATP binding
K80E K84E 20 ATP hydrolysis
G94S G98S 8 ATP binding
S102R S106R 7 ATP binding
R176G R182G 14 DNA binding
G234V G244V 6 DNA binding
R256C R265C 53 ATP binding
a

A list of MLH1 mutations, the corresponding B. subtilis missense mutations, the reported incidence in HNPCC patients, and the possible MutL functions impaired by each mutation is shown.

b

The occurrence of each human MLH1 missense mutation was obtained from the International Society for Gastrointestinal Tumors (www.insight-group.org).

c

Potential function refers to the predicted biochemical function affected by each mutation based on the corresponding missense mutation location in S. cerevisiae Mlh1 or E. coli MutL where the biochemical defect has been determined (2, 26).